Abbott Vascular
3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
http://www.abbottvascular.com
Product Categories
Embolic Protection Devices, Stents, Stents Drug Eluting, Vascular Closure Devices, Stents Carotid, Stents Peripheral, Stents Bare Metal

Related Content

Abbott Announces MR-Conditional Labeling for Quadra Assura CRT-D and Fortify Assura ICD
Technology | Cardiac Resynchronization Therapy Devices (CRT)
Abbott Announces MR-Conditional Labeling for Quadra Assura CRT-D and Fortify Assura ICD

January 3, 2018 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR) ...

Home January 03, 2018
arrow
The Xience Sierra stent.
Technology | Stents Drug Eluting
Abbott Gains European Approval for Xience Sierra Stent

November 9, 2017 — Abbott received European CE mark for Xience Sierra, the newest generation of the company's Xience ...

Home November 09, 2017
arrow
The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was in October 2017.
Feature | Dave Fornell
Most Popular Cardiac Technology Content in October 2017 on DAIC

November 3, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...

Home November 03, 2017
arrow
Thirty-Day ABSORB IV Results Demonstrate Improvements Still Needed in Bioresorbable Stents
News | Stents Bioresorbable
Thirty-Day ABSORB IV Results Demonstrate Improvements Still Needed in Bioresorbable Stents

October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular ...

Home October 31, 2017
arrow
FDA Investigating Increased Major Adverse Cardiac Event Rates of Absorb Bioresorbable Stent
News | Stents Bioresorbable
FDA Investigating Increased Major Adverse Cardiac Event Rates of Absorb Bioresorbable Stent

October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim ...

Home October 31, 2017
arrow
Abbott SJM St. Jude Confirm RX implantable cardiac monitor (ICM).
Technology | Implantable Cardiac Monitor (ICM)
First Smartphone Compatible Insertable Cardiac Monitor Cleared by FDA

October 23, 2017 – The U.S. Food and Drug Administration (FDA) has cleared Abbott’s Confirm Rx Insertable Cardiac ...

Home October 23, 2017
arrow
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD

September 22, 2017 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR) ...

Home September 22, 2017
arrow
Abbott will end sales of the Absorb bioresorbable stent scaffold, pulling it off the market September 14, 2017.
Feature | Stents Bioresorbable| Dave Fornell
Abbott Will End Sales of Absorb Bioresorbable Stent

September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular ...

Home September 08, 2017
arrow
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial

September 5, 2017 — Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a ...

Home September 05, 2017
arrow
Abbott Initiates U.S. Pivotal Study of Amplatzer Device for Patent Ductus Arteriosus
News | Congenital Heart
Abbott Initiates U.S. Pivotal Study of Amplatzer Device for Patent Ductus Arteriosus

September 5, 2017 — Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and ...

Home September 05, 2017
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now